Making an Informed Treatment Choice for Aggress...
Risk group, therapy, and second malignant neopl...
Frontiers | Predicting pathological complete re...
Overview of the NOPHO 92 Protocol | Download Table
Activation of hepatic Nogo-B receptor expressio...
Do cancer cells die because of Nogo-B? | Oncogene
Nogo-B regulates endothelial sphingolipid homeo...
Long-term results of NOPHO ALL-92 and ALL-2000 ...
Central Nervous System Prophylaxis and Treatmen...
Oncology Brothers on Twitter: "Neoadj Nivolumab...
IJMS | Free Full-Text | Enhanced Chemosensitivi...
Knockout of the Nogo-B Gene Attenuates Tumor Gr...
Frontiers | The safety of neoadjuvant chemother...
NSSG Chemotherapy Protocol / nssg-chemotherapy-...
Thromboembolism in acute lymphoblastic leukemia...
Enhanced Chemosensitivity by Targeting Nanog in...
Nogo-B receptor increases the resistance to tam...
Nogo-B Promotes Angiogenesis And Improves Cardi...
Frontiers | Upfront Treatment of Pediatric High...
Nogo‐B receptor is necessary for cellular dolic...
Nogo‑B receptor in relevant carcinoma: Current ...
20220611020649 - New